| Spain's Faes ties up major partner for anti-allergy drug bilastine
Spanish drugmaker Faes Farma says that it is close to signing an agreement with an unnamed "multinational pharmaceutical company" to market its potential blockbuster oral anti-allergy drug bilastine in Europe.
The Bilbao-headquartered firm said that the pact includes 40 European countries, with the exception of Spain and Portugal where it will market the drug itself, and Faes will receive milestones and royalty payments in each country covered under the agreement. The company added that it is reserving the right to grant secondary co-marketing licences for bilastine to other drugmakers in the larger European countries such as France, Germany, Italy and the UK.
A Faes spokeswoman refused to be drawn on the identity of the partner in question but told PharmaTimes World News that the deal should be signed and sealed before the end of the second quarter.
My kind of town: Madrid
I lived here for three years while writing The Spanish Game, a novel about a British spy who becomes embroiled in a Basque separatist plot. My wife was a teacher at an international school in the city and we still regularly return to visit friends, eat great food and watch Real Madrid at the Bernabéu. What do you miss most when you're away? .
|
